Sign inJoin waitlistJoin the waitlist

Michael Jelinek

Associate Program Director, Hematology-Oncology Fellowship · Rush University Medical Center

Credentials: · · · ·

History

Hematology-Oncology Fellowship · Rush University Medical Center
Present
Rush University Medical Center
Present

Hematology and Medical Oncology
University of Chicago Medical Center
2016–2019
Internal Medicine
University of Chicago Medical Center
2013–2016
Rush Medical College
2009–2013

Research

A Phase 1 Trial of Concurrent or Sequential Ipilimumab, Nivolumab, and Stereotactic Body Radiotherapy in Patients With Stage IV NSCLC Study
Journal of Thoracic Oncology · 2022 · 124 citations
Neoadjuvant Nivolumab Plus Chemotherapy Followed by Response-Stratified Chemoradiation Therapy in HPV-Negative Head and Neck Cancer: The DEPEND Phase 2 Nonrandomized Clinical Trial
JAMA Oncology · 2025 · 29 citations
Current State and Future Directions of EGFR-Directed Therapy in Head and Neck Cancer
Review · Current Treatment Options in Oncology · 2023 · Last of 3 authors · Corresponding · 22 citations

Samer Al-Khudari
7 papers
Mihir Bhayani
6 papers
Everett Vokes
5 papers
Kerstin Stenson
5 papers
Jayant Pinto
3 papers
Mary Fidler
3 papers
Nikhil Joshi
3 papers
Aditya Juloori
2 papers
Bobby Tajudeen
2 papers
Daniel Haraf
2 papers
Evan Patel
2 papers · 2 as a fellow
Jyoti Patel
2 papers